DFCM
LXRX icon

Dark Forest Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Dark Forest Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,875
Closed -$36.4K – 1207
2023
Q2 		$36.4K Buy
+15,875
New +$42.1K ﹤0.01% 989
2022
Q4 		– Sell
-35
Closed – – 1343
2022
Q3 		$0 Buy
+35
New +$97 ﹤0.01% 1306

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Dark Forest Capital Management's LXRX Position: Q3 2023 in Review

Dark Forest Capital Management sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2023, closing a stake of 15,875 shares — an estimated $36.4K sold.

Dark Forest Capital Management first reported a position in LXRX in Q3 2022 and held it in 2 quarters. The position peaked at $36.4K in Q2 2023. 112 funds tracked by Wall St. Rank hold LXRX as of Q3 2023.

  • Dark Forest Capital Management reported no remaining Lexicon Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 15,875 Lexicon Pharmaceuticals shares in Q3 2023, an estimated $36.4K.
  • Dark Forest Capital Management first reported a position in Lexicon Pharmaceuticals in Q3 2022 and held it in 2 quarters.
  • Dark Forest Capital Management's Lexicon Pharmaceuticals position peaked at $36.4K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2023.

Based on Dark Forest Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.